meprobamate

Key facts

INN

meprobamate

Brand

MEPROBAMATE

Route

ORAL

Formulation

CAPSULE

Originator

TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 12390419

Formulations of (R)-2-amino-3-phenylpropyl carbamate

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12384743

Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11998639

Formulations of (R)-2-amino-3-phenylpropyl carbamate

Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11560354

Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11439597

Formulations of (R)-2-amino-3-phenylpropyl carbamate

Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10829443

Solvate form of (R)-2-amino-3-phenylpropyl carbamate

Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10512609

Formulations of (R)-2-amino-3-phenylpropyl carbamate

Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10233174

Thiocarbamate prodrugs of tofacitinib

Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is meprobamate?

meprobamate (MEPROBAMATE), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for meprobamate?

MEPROBAMATE is a marketed brand name for meprobamate. Check FDA Drugs@FDA for the current US label holder.